Lepirudin April 17, 2017 Lepirudin Trade Name Refluden Orphan Indication Heparin-associated thrombocytopenia type II USA Market Approval USA USA Designation Date 1997-02-13 00:00:00 Sponsor Hoechst Marion Roussel;Frankfurt am Main, P.O. Box 1140;Marburg
